Reduced diffusing capacity of the lungs for carbon monoxide (DLco) reflects microvasculopathy in chronic thromboembolic ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Omega-3 fatty acid intake may improve lung function and ...
A pair of studies presented at the European Respiratory Society Congress 2024 emphasized the importance of close monitoring and proactive treatment approaches for patients with idiopathic (IPF) and ...
The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.
The Social Security Administration has requested the National Academies of Sciences, Engineering, and Medicine to review the latest published research and science and produce a report addressing best ...
A recent study published in the journal PLoS ONE reports that patients with severe coronavirus disease 2019 (COVID-19) are at a higher risk of experiencing persistent pulmonary impairments, even 12 ...
Sept 25 (Reuters) - The World Anti-Doping Agency (WADA) will add the non-diagnostic use of carbon monoxide to its prohibited methods list from next year, the organisation said. The gas is used in low ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback